Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients.
Sobi has been involved in the development and manufacturing ofrecombinant protein drugssince the technology was first developed more than30 years ago.
We want to make a differenceto people with rare diseases.
By working closely with patients and their relatives we learn about their daily challenges and needs.
Sobi Interim Report Q3 2014
pdf-format, 949 KB
Sobi Interim Report Q2 2014
pdf-format, 1.03 MB
Sobi Interim Report Q1 2014
pdf-format, 1011 KB
Full Year Report 2013
pdf-format, 1.11 MB
Sobi Interim Report Q3 2013.pdf
pdf-format, 1.8 MB
Sobi Interim Report Q2 2013.pdf
pdf-format, 1.84 MB
Swedish Orphan Biovitrum AB (publ)
SE-112 76 Stockholm, SwedenPhone: +46 8 697 20 00
© Swedish Orphan Biovitrum AB, 2013